Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients.

Johannet, Paul; Sawyers, Amelia; Gulati, Nicholas; Donnelly, Douglas; Kozloff, Samuel; Qian, Yingzhi; Floristan, Alfredo; Hernando, Eva; Zhong, Judy; Osman, Iman

Johannet, Paul; Sawyers, Amelia; Gulati, Nicholas; Donnelly, Douglas; Kozloff, Samuel; Qian, Yingzhi; Floristan, Alfredo; Hernando, Eva; Zhong, Judy; Osman, Iman.

Afiliación

Johannet P; Department of Medicine, NYU Langone Health, New York, USA.
Sawyers A; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA.
Gulati N; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA.
Donnelly D; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA.
Kozloff S; Department of Medicine, NYU Langone Health, New York, USA.
Qian Y; Department of Population Health, NYU Langone Health, New York, USA.
Floristan A; Department of Pathology, NYU Langone Health, New York, USA.
Hernando E; Department of Pathology, NYU Langone Health, New York, USA.
Zhong J; Department of Population Health, NYU Langone Health, New York, USA.
Osman I; Ronald O. Perelman Department of Dermatology, NYU Langone Health, New York, USA. Iman.Osman@nyulangone.org.

J Transl Med ; 19(1): 47, 2021 01 30.

Article en En | MEDLINE | ID: mdl-33516263

Asunto(s)

Inmunoterapia; Neoplasias; Anticoagulantes/uso terapéutico; Humanos; Neoplasias/tratamiento farmacológico; Supervivencia sin Progresión; Resultado del Tratamiento

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Transl Med Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google